First electrochemical evaluation of favipiravir used as an antiviral option in the treatment of COVID-19: A study of its enhanced voltammetric determination in cationic surfactant media using a boron-doped diamond electrode()

Favipiravir, a promising antiviral agent, is undergoing clinical trials for the potential treatment of the novel coronavirus disease 2019 (COVID-19). This is the first report for the electrochemical activity of favipiravir and its electroanalytical sensing. For this purpose, the effect of cationic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Allahverdiyeva, Shabnam, Yunusoğlu, Oruc, Yardım, Yavuz, Şentürk, Zühre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971419/
https://www.ncbi.nlm.nih.gov/pubmed/33867032
http://dx.doi.org/10.1016/j.aca.2021.338418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971419/
https://www.ncbi.nlm.nih.gov/pubmed/33867032
http://dx.doi.org/10.1016/j.aca.2021.338418

Ejemplares similares